Clinical and Molecular Hepatology (대한간학회지)

The Korean Association for the Study of the Liver (대한간학회)
권호 표지

Epidemiology of Hepatocellular Carcinoma in Korea

한국인 간세포암종의 역학

Park, Joong-Won;Kim, Chang-Min
박중원;김창민

  • Published : 20051200
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. 통계청 사망원인통계. http://www.nso.go.kr
  2. 보건복지부 중앙암등록본부 암발생 통계 1999-2001. http: //www.mohw.go.kr
  3. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:5-16
  4. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. Volume VIII. IARC Sci Publ. No. 155 Lyon, 2002
  5. World Health Organization. World cancer report 2003, IARC Press, Lyon 2003
  6. 통계청 2003년 사망원인 통계연보, 서울, 2004
  7. Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004;96:1851- 1856 https://doi.org/10.1093/jnci/djh334
  8. 김창민. 간세포암종의 역학 및 병인. 김정룡 편저. 소화기 계질환. 서울: 일조각, 2005
  9. International Agency for Research on Cancer. IARC monograph on the evaluation of carcinogenic risks to humans. vol 83, Lyon 2004
  10. Cheon JH, Park JW, Park KW, et al. The Clinical Report of 1,078 Cases of Hepatocellular Carcinomas: National Cancer Center Experience. Korea J Hepatol 2004;10:288-297
  11. 엄순호. Recent trends of HCC in Korea. 대한간암연구회 제8차 학술심포지엄 2005;17-25
  12. 박중원. 국가 간암 조기검진사업. 대한간학회지 2002;8 (suppl 3):16-19
  13. Park JW. Recent epidemiology of hepatocellular carcinoma in Korea. APDW postgraduate course and proceedings 2005;131
  14. 박경우, 박중원, 김영일 등. 간세포암종 환자의 단기 생존 율 분석: 병기별 치료 성적. 소화기연관학회 추계합동학술 대회 초록집 2004;390
  15. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35: 519-524 https://doi.org/10.1053/jhep.2002.32089
  16. Llovet JM. Evidence-based medicine in the treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 2002;17: 428-433 https://doi.org/10.1046/j.1440-1746.17.s3.40.x
  17. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbitati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655-661
  18. Mezzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699 https://doi.org/10.1056/NEJM199603143341104
  19. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359: 1734-1739 https://doi.org/10.1016/S0140-6736(02)08649-X
  20. Lee HS, Kim KM, Yoon JH, et al. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. J Clin Oncol 2002;20:4459-4465 https://doi.org/10.1200/JCO.2002.02.013
  21. Seong J, Park HC, Han KH, Chon CY. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 2003;55:329-336 https://doi.org/10.1016/S0360-3016(02)03929-9
  22. Johnson PJ. Is there a role for systemic therapy in hepatocellular carcinoma, and if so, can we assess response? Educational book, American Society of Clinical Oncology 2002